SCHEMBL4463022

SCHEMBL4463022

CN1C(=O)OC(c2cccnc2)C1c1ccc(-c2ccccc2)c(OC(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.39
TNKS O95271 2/20 0.36
CYP2C9 P11712 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP11B1 P15538 3/20 0.35
CYP11B2 P19099 3/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
CYP3A4 P08684 3/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 3/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 1/20 0.34
THPO P40225 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SCN9A Q15858 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4472192 0.82 GRM2 (0.35) MDM2PDE3BPDE3ASCN9A
SCHEMBL4463013 0.82 TNKS (0.41) TNKSCYP1A2CYP11B1CYP11B2CYP3A4
SCHEMBL4449987 0.72 HCRTR1 (0.39) PDE3BPDE3A
SCHEMBL4445385 0.69 PGR (0.40) MEN1KMT2ACYP3A4HSD17B10KDM4E
SCHEMBL4474719 0.67 PDE3B (0.39) PDE3BPDE3A
SCHEMBL15744020 0.67 KDM4E (0.49) MDM2CYP2C9CYP1A2MEN1KMT2A
SCHEMBL15744004 0.67 KDM4E (0.49) MDM2CYP2C9CYP1A2MEN1KMT2A
SCHEMBL4460630 0.66 GRM2 (0.41) KMT2AHSD17B10KDM4ETSHRMAPK1
SCHEMBL4445299 0.66 ALDH1A1 (0.39) MDM2MEN1KMT2ACYP3A4HSD17B10
SCHEMBL4472187 0.66 GRM2 (0.36) PDE3BPDE3ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 MDM2 2457/4885TNKS 3250/4885CYP2C9 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.